Opus Genetics Income Statement (2010-2026) | IRD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.10M	0.49M					39.85M	1.75M	3.67M	11.94M	1.69M	1.71M	1.11M	3.87M	4.30M	4.37M	2.88M	3.08M	3.87M	2.16M
Operating items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	3.83M	3.13M	4.74M	4.77M	3.16M	2.83M	3.59M	5.59M	4.72M	3.49M	3.84M	4.75M	6.09M	8.98M	7.03M	7.95M	6.02M	6.41M	10.43M	10.58M
Selling, General & Administrative (Quarter)	3.41M	1.59M	1.41M	1.74M	1.78M	1.70M	2.05M	2.29M	4.34M	2.06M	3.28M	4.67M	3.35M	2.89M	7.30M	6.35M	5.77M	4.98M	4.89M	5.94M
Other Operating Expenses (Quarter)															28.00M
Operating Expenses (Quarter)	7.24M	4.72M	6.15M	6.51M	4.94M	4.54M	5.64M	7.88M	9.06M	5.55M	7.12M	9.42M	9.44M	11.88M	42.33M	14.30M	11.79M	11.39M	15.32M	16.52M
Operating Income (Quarter)	-7.14M	-4.23M	-6.15M	-6.51M	-4.94M	-4.54M	34.21M	-6.13M	-5.39M	6.39M	-5.43M	-7.71M	-8.33M	-8.01M	-38.03M	-9.93M	-8.91M	-8.31M	-11.45M	-14.36M
EBIT (Quarter)	-7.14M	-4.23M	-6.15M	-6.51M	-4.94M	-4.54M	34.21M	-6.13M	-5.39M	6.39M	-5.43M	-7.71M	-8.33M	-8.01M	-38.03M	-9.93M	-8.91M	-8.31M	-11.45M	-14.36M
Non-operating items
Non Operating Investment Income (Quarter)										0.06M	0.02M				0.07M	2.81M	0.92M	-9.53M	-5.71M	-51.36M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.00M	0.00M	-0.16M	-0.08M	0.01M	0.01M	0.05M	0.34M	0.43M	0.46M	0.61M	0.60M	0.56M	0.48M	2.82M	0.30M	0.53M	0.45M	0.70M	0.84M
Non Operating Income (Quarter)	0.00M	0.00M	-0.16M	-0.08M	0.01M	0.01M	0.05M	0.34M	0.43M	0.46M	0.61M	0.60M	0.56M	0.48M	2.82M	0.30M	0.53M	0.45M	0.70M	0.84M
Net income details
EBT (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	34.26M	-5.79M	-4.96M	5.58M	-4.80M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Tax Provisions (Quarter)							0.32M			0.01M	-0.00M
Profit After Tax (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Income from Continuing Operations (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Consolidated Net Income (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Income towards Parent Company (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Net Income towards Common Stockholders (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Additional items
EPS (Basic) (Quarter)	-0.52	-0.25	-0.18	-0.35	-0.25	-0.22	1.72	-0.28	-0.24	0.26	-0.21	-0.29	-0.30	-0.29	-1.27	-0.24	-0.12	-0.25	-0.21	-0.75
EPS (Weighted Average and Diluted) (Quarter)	-0.52	-0.25	-0.18	-0.35	-0.25	-0.22	1.69	-0.28	-0.24	0.25	-0.21	-0.29	-0.30	-0.29	-1.27	-0.24	-0.12	-0.25	-0.21	-0.75
Shares Outstanding (Weighted Average) (Quarter)	13.61M	13.84M	14.85M	18.89M	0.06M	20.50M	19.93M	1.54M	20.96M	21.12M	21.59M	1.54M	25.83M	26.15M	26.72M	29.43M	63.38M	56.10M	22.90M	22.90M
Shares Outstanding (Diluted Average) (Quarter)	12.27M	13.84M	14.85M	18.89M	19.20M	19.64M		20.94M	20.95M		21.59M	24.52M	25.83M	26.15M	26.72M	33.88M	48.71M	70.64M	62.22M	86.89M
EBITDA (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Interest Expenses (Quarter)			0.00M	0.01M	0.00M													0.07M	0.06M	0.07M
Tax Rate (Quarter)							0.92%			0.25%	0.04%

Research Tools

Opus Genetics Income Statement (2010-2026) | IRD

Create an account

Sign In

Reset Password